Yao Lv
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 6
- Gut microbiota and health 3
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Li‐Min Zhu (3 shared papers)Heyu Li (2 shared papers)Gareth R. Williams (2 shared papers)Xiaoqiang Guo (4 shared papers)Shifei Huang (5 shared papers)Huihui Yang (2 shared papers)Lei Tao (2 shared papers)Yufeng Zhao (4 shared papers)
- Journals
- Oncotarget (3 papers)Medicine (3 papers)Environmental Pollution (2 papers)Journal of Building Engineering (2 papers)Rare Metals (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yao Lv
99 papers receiving 1.9k citations
Yao Lv's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 344
- Biomaterials 235
- Pollution 129
- Rehabilitation 65
- Health, Toxicology and Mutagenesis 123
Countries citing papers authored by Yao Lv
This map shows the geographic impact of Yao Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Lv more than expected).
Fields of papers citing papers by Yao Lv
This network shows the impact of papers produced by Yao Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Lv. The network helps show where Yao Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Yao Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer Hit paper breakdown → | 2022 | 133 |
| 2 | 2019 | 130 | |
| 3 | 2016 | 109 | |
| 4 | 2022 | 101 | |
| 5 | 2016 | 95 | |
| 6 | 2021 | 86 | |
| 7 | 2015 | 74 | |
| 8 | 2021 | 73 | |
| 9 | 2017 | 71 | |
| 10 | 2011 | 51 | |
| 11 | 2018 | 45 | |
| 12 | 2011 | 45 | |
| 13 | 2019 | 40 | |
| 14 | 2019 | 39 | |
| 15 | 2018 | 37 | |
| 16 | 2018 | 32 | |
| 17 | 2020 | 31 | |
| 18 | 2018 | 30 | |
| 19 | 2011 | 29 | |
| 20 | 2018 | 27 |
About Yao Lv
Yao Lv is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering, having authored 101 papers that have together received 1.9k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (7 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers), Sperm and Testicular Function (6 papers), Supercapacitor Materials and Fabrication (5 papers), Cancer-related molecular mechanisms research (4 papers), Microfluidic and Bio-sensing Technologies (4 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Cancer Research (344 citations), Biomaterials (235 citations), Pollution (129 citations), Rehabilitation (65 citations) and Health, Toxicology and Mutagenesis (123 citations). Yao Lv has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Li‐Min Zhu, Heyu Li, Gareth R. Williams, Xiaoqiang Guo, Shifei Huang, Huihui Yang, Lei Tao, Yufeng Zhao, Yaoting Gui and Jiujun Zhang. Their work appears in journals such as Oncotarget, Medicine, Environmental Pollution, Journal of Building Engineering and Rare Metals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.